91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Recent advancements in obesity treatments have spotlighted the field for healthcare providers and developers. In this article from Drug Discovery World, 91黑料 experts share insights on the clinical trials landscape for obesity and why patient centricity is key to overcoming common challenges in the sector.
-
In this article from The Scientist, Rose Kidd, President of Global Operations Delivery, explains how clinical researchers ensure impeccable data collection and delivery in increasingly complex trials.
-
In this article from Contract Pharma, Kelly Corkey, Director, Clinical Supplies Management, IRT provides commentary on how clinical supply services are changing as next-gen biotherapeutics and direct-to-patient trials transform the clinical research arena, disrupting the traditional supply models.
-
Rick Rosenthal and Paula Fullman of Symphony Health, an 91黑料 plc company, explain how to navigate the complexities and challenges of the evolving digital landscape of healthcare data in this article from PharmaTimes.
-
This article in the Business Post lists 91黑料 as the winner of the Social and Equality Business of the Year Award category of the 2024 PwC Business Post Sustainable Business Awards.
-
In Dr Tanja Obradovic's article in The Cancer Letter, she discusses how to navigate early clinical development and support robust registrational strategy and late-stage development in oncology.
-
This article in Applied Clinical Trials by Tinaya Gray, Global Head of Diversity & Inclusion in Clinical Trials discusses how technology can offer opportunities to leverage tailored solutions that can help drive inclusive diversity in clinical research, to help increase participation from underrepresented patient populations.
-
In an interview with Contract Pharma, 91黑料’s Adrienne Stoudenmire and Alan Baldridge discuss current obesity R&D trends, challenges associated with obesity-related clinical research, and opportunities in this sector.
-
91黑料’s Simon Bruce, Vice President of Internal Medicine and Drug Development Solutions sits down for a Q&A with Pharmaceutical Executive and gives an overview on the obesity survey carried out by 91黑料 in January 2024 and what it suggests about the state of the obesity-related pipeline.
-
In this article from Fierce Biotech, Chris Smyth, President of 91黑料 Biotech outlines reasons for optimism in 2024, as the biotech sector looks to bounce back after several challenging years.
